4.5 Article

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Efficacy of pneumococcal vaccination in adults: a meta-analysis

Anke Huss et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)

Review Medicine, General & Internal

Vaccines for preventing pneumococcal infection in adults

S. A. Moberley et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)

Article Infectious Diseases

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries

S. M. A. A. Evers et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)

Article Geriatrics & Gerontology

Advances in pneumococcal vaccines - What are the advantages for the elderly?

Angel Vila-Corcoles

DRUGS & AGING (2007)

Review Microbiology

Streptococcus pneumoniae protein vaccine candidates:: Properties, activities and animal studies

Stanley S. Tai

CRITICAL REVIEWS IN MICROBIOLOGY (2006)

Review Critical Care Medicine

Streptococcus pneumoniae:: Epidemiology, risk factors, and clinical features

Å Örtqvist et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

Review Immunology

Pneumococcal vaccines:: an update on current strategies

D Bogaert et al.

VACCINE (2004)

Article Medicine, General & Internal

Effectiveness of pneumococcal polysaccharide vaccine in older adults

LA Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)